CTLA4Ig inhibits alloantibody responses to repeated blood transfusions

Blood

Volumn 88, Issue 12, 1996, Pages 4594-4600

  Ibrahim, Sherif ^b   Jakobs, Frank ^b   Kittur, Dilip ^b   Hess, Allan ^b   Linsley, Peter S ^b   Sanfilippo, Fred ^b   Baldwin III, William M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; CONTROLLED STUDY; FLOW CYTOMETRY; HELPER CELL; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; STEM CELL;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BLOOD TRANSFUSION; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; MALE; RATS; RATS, INBRED ACI; RATS, INBRED LEW; RETREATMENT;

EID: 0029856233     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD: Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 34:562, 1994
2. Hussein MA, Lee EJ, Fletcher R, Schiffer CA: The effects of lymphocytotoxic antibody reactivity on the results of single antigen mismatched platelet transfusions to alloimmunized patients. Blood 87:3959, 1996
3. O'Connel BA, Lee EJ, Rothko K, Hussein MA: Selection of histocompatible aphoresis platelet donors by cross-matching random donor platelet concentrates. Blood 79:527, 1992
4. Andreu G, Dewailly J, Leberre C, Quarre MC, Bidet ML, Tardivel R, Devers L, Lam Y, Soreau E, Boccaccio C: Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration. Blood 72:964, 1988
5. Saarinen UM, Kekomaki R, Siimes MA, Myllyla G: Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components. Blood 75:512, 1990
6. Sniecinski I, O'Donnell MR, Nowicki B, Hill LR: Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 71:1402, 1988
7. Farrugia A, Shea N, Knowles S, Holdsworth R, Piouronowski H, Portbury D, Romeo A: Cryopreservation of red blood cells: Effect of freezing on red cell quality and residual lymphocyte immunogenicity. J Clin Pathol 46:742, 1993
8. Schiffer CA, Hogge DE, Aisner J, Dutcher JP, Lee EJ, Papenberg D: High-dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients. Blood 64:937, 1984
9. Zeigler ZR, Shadduck RK, Rosenfeld CS: Intravenous gamma globulin decreases platelet-associated IgG and improves transfusion responses in platelet refractory states. Am J Hematol 38:15, 1991
10. van Marwijk KM, van Prooijen HC, Moes M, Bosma-Stants I, Akkerman JW: Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: A prospective, randomized trial. Blood 77:201, 1991
11. Nencioni L, Mancini C, Pini C, Doria G: T-cell-dependent oscillations of IgM antibody affinity during the immune response to DNP-dextran to low or high epitope density. Immunology 47:123, 1982
12. Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, Covey LR, Lee JJ, Rothman P, Chess L: T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 152:2163, 1994
13. Shoskes DA, Wood KJ: Indirect presentation of MHC antigens in transplantation. Immunol Today 15:32, 1994
14. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM: Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84:3261, 1994
15. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356:607, 1992
16. Schwartz RH: Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065, 1992
17. Lenshow DL, Zeng Y, Richard T, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789, 1992
18. Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CP, Turka LA: Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced CTLA4Ig plus donor-specific transfusion. J Exp Med 178:1801, 1993
19. Linsley PS, Wallace PM, Johnson J, Gibson MG, Greene JL, Ledbetter JA, Singh C, Tepper MA: Immunosuppression in vivo by a soluble form of CTLA-4Ig T cell activation molecule. Science 257:792, 1992
20. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA: CTLA-4 is a second receptor for the T cell activation antigen B7. J Exp Med 174:561, 1991
21. Wray DW, Baldwin WM III, Sanfilippo F: IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection: Effects of transplantectomy and posttransplantation blood transfusions. Transplantation 53:167, 1992
22. Fischer AC, Ruvolo PP, Burt R, Horwitz LR, Bright EC, Hess JM, Beschorner WE, Hess AD: Characterization of the autoreactive T cell repertoire in cyclosporine-induced syngenic graft-versus-host disease. J Immunol 154:3713, 1995
23. Capon DJ, Chamow SM, Mordenti J, Marsters SA, Gregory T, Mitsuya H, Byrn RA, Lucas C, Wurm FM, Groopman JE, Broder S, Smith DH: Designing CD4 immunoadhesins for AIDS therapy. Nature 337:525, 1989
24. Janeway CA, Merler E, Rosen FS, Salmon S, Crain JD: Intravenous gamma globulin: Metabolism of gamma globulin fragments in normal and agammaglobulinemic persons. N Engl J Med 278:919, 1968
25. Mankarious S, Lee M, Fischer S, Pyun KH, Ochs HD, Oxelius VA, Wedgwood RJ: The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin. J Lab Clin Med 112:634, 1988
26. Wasowska B, Baldwin WM III, Sanfilippo F: IgG alloantibody responses to donor specific blood transfusion in different rat strain combinations are predictive of renal allograft survival. Transplantation 53:175, 1992
27. Ibrahim S, Xu R, Burdick JF, Baldwin W, Sanfilippo F, Kittur DS: CTLA4Ig inhibits humoral and cellular immune responses to concordant xenografts. Transplant Proc 28:715, 1996
28. Wallace PM, Rodgers JN, Leytze GM, Johnson JS, Linsley PS: Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA41g treatment. J Immunol 154:5885, 1995
29. Gimmi CD, Freeman GJ, Gribben J, Nadler LM: Human T cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 90:6586, 1993
30. Judge AT, Tang A, Spain LM, Gratiot-Deans J, Sayegh MH, Turka LA: The in vivo mechanism of action of CTLA4Ig. J Immunol 156:2294, 1996
31. Peppard JV, Orlane E: The biological half-lives of four rat immunoglobulin isotypes. Immunology 40:683, 1980